Consolidated statement of changes in shareholders' equity - EUR (€) |
Share capital |
Premiums related to share capital |
Net profit (loss) |
Translation reserves |
Reserves (Accumulated losses) |
Total |
|---|---|---|---|---|---|---|
| Balance at the beginning at Dec. 31, 2022 | € 421,341 | € 173,885,665 | € (54,274,000) | € (271,000) | € (74,286,000) | € 45,476,000 |
| Balance at the beginning (in shares) at Dec. 31, 2022 | 42,134,169 | |||||
| Net loss for the period | (110,426,000) | (110,426,000) | ||||
| Remeasurement of defined benefit plans | (97,000) | (97,000) | ||||
| Currency translation differences | 867,000 | 867,000 | ||||
| Total comprehensive loss | (110,426,000) | 867,000 | (97,000) | (109,656,000) | ||
| Appropriation of net income (loss) | 54,274,000 | (54,274,000) | ||||
| Issue of ordinary shares | € 96,000 | 30,491,000 | 30,587,000 | |||
| Issue of ordinary shares (in shares) | 9,618,638 | |||||
| Transaction costs | (2,511,000) | (2,511,000) | ||||
| Vesting of bonus shares (in shares) | 363,000 | |||||
| Vesting of bonus shares | € 4,000 | (4,000) | ||||
| Share-based payment compensation expenses | 3,969,000 | 3,969,000 | ||||
| BSA share warrants subscription premium | 2,000 | 2,000 | ||||
| Treasury shares | 134,000 | 134,000 | ||||
| Other | (33,000) | (33,000) | ||||
| Balance at the end (in shares) at Dec. 31, 2023 | 52,115,807 | |||||
| Balance at the end at Dec. 31, 2023 | € 521,158 | 201,862,263 | (110,426,000) | 596,000 | (124,584,000) | (32,032,000) |
| Net loss for the period | (184,212,000) | (184,212,000) | ||||
| Remeasurement of defined benefit plans | (1,000) | (1,000) | ||||
| Currency translation differences | 4,000 | 4,000 | ||||
| Total comprehensive loss | (184,212,000) | 4,000 | (1,000) | (184,209,000) | ||
| Appropriation of net income (loss) | 110,426,000 | (110,426,000) | ||||
| Issue of ordinary shares | € 425,000 | 56,913,000 | 57,338,000 | |||
| Issue of ordinary shares (in shares) | 42,472,571 | |||||
| Transaction costs | (9,605,000) | (9,605,000) | ||||
| Issue of prefunded warrants | 58,227,000 | 58,227,000 | ||||
| Vesting of bonus shares (in shares) | 1,074,013 | |||||
| Vesting of bonus shares | € 11,000 | (11,000) | ||||
| Share-based payment compensation expenses | 3,580,000 | 3,580,000 | ||||
| BSA share warrants subscription premium | 6,000 | 6,000 | ||||
| Treasury shares | (81,000) | (81,000) | ||||
| Other | 128,000 | 128,000 | ||||
| Balance at the end (in shares) at Dec. 31, 2024 | 95,662,391 | |||||
| Balance at the end at Dec. 31, 2024 | € 956,624 | 249,159,597 | (184,212,000) | 600,000 | (173,151,000) | (106,647,000) |
| Net loss for the period | (354,138,000) | (354,138,000) | ||||
| Remeasurement of defined benefit plans | 149,000 | 149,000 | ||||
| Currency translation differences | 36,000 | 36,000 | ||||
| Total comprehensive loss | (354,138,000) | 36,000 | 149,000 | (353,954,000) | ||
| Appropriation of net income (loss) | 184,212,000 | (184,212,000) | ||||
| Issue of ordinary shares | € 967,000 | 296,214,000 | (12,559,000) | 284,621,000 | ||
| Issue of ordinary shares (in shares) | 96,666,831 | |||||
| Transaction costs | (17,134,000) | (17,134,000) | ||||
| Issue of prefunded warrants | 138,130,000 | 138,130,000 | ||||
| Vesting of bonus shares (in shares) | 907,756 | |||||
| Vesting of bonus shares | € 9,000 | (9,000) | ||||
| Share-based payment compensation expenses | 26,769,000 | 26,769,000 | ||||
| Treasury shares | 171,000 | 171,000 | ||||
| Other | (478,000) | € (478,000) | ||||
| Balance at the end (in shares) at Dec. 31, 2025 | 193,236,978 | 193,236,978 | ||||
| Balance at the end at Dec. 31, 2025 | € 1,932,370 | € 528,230,262 | € (354,138,000) | € 636,000 | € (205,182,000) | € (28,522,000) |